AnaptysBio Secures $2,022,117 New Financing Round

  • Feed Type
  • Date
    10/11/2013
  • Company Name
    AnaptysBio
  • Mailing Address
    10421 Pacific Center Court San Diego, CA 92121
  • Company Description
    Founded in 2005, AnaptysBio is a privately-held therapeutic antibody company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body’s natural process for generating potent antibodies to fight disease.
  • Website
    http://www.anaptysbio.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,022,117
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed